Lee Scott Golden Receives Stock Award at Cadrenal Therapeutics Inc (CVKD) — SEC Form 4, Dec 04, 2025
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Lee Scott Golden CIK 0001686217 |
Director
|
Lee Scott Golden at Cadrenal Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Cadrenal Therapeutics Inc
| 2026-10-13 | Award | — | View |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $8.27 | 2025-12-02 | A - Award/Grant | 5,000 A | $0.00 | 2035-12-01 | 5,000 Common Stock | Direct |
Footnotes (1)
- F1
- Consists of options to purchase 5,000 shares of common stock, which shall vest 1/3 on January 1, 2027 and thereafter pro rata on a monthly basis over 24 months, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to the fair market value of the Issuer's common stock on the effective date of the grant. Show more
Related filings at Cadrenal Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
17
institutional managers reporting a position
Largest by reported value
- Vanguard Capital Management Llc $167K
- Hrt Financial Lp $97K
- Geode Capital Management, Llc $63.5K
5%+ Holders · 13D/G
2 filers
-
Quang X. Pham 23.6%
Other insiders at Cadrenal Therapeutics Inc
GET /v1/forms/4/0001213900-25-118003
API docs
View Original SEC Filing